国药三益在医疗器械行业中的票数：100
【国药三益是哪个国家的品牌？】
国药集团三益药业（芜湖）有限公司，成立于2012年12月，省级高新技术企业，是上海现代制药股份有限公司（股票代码600420）和国药控股股份有限公司（股票代码：01099.HK）合资的控股子公司，是中国医药集团内专业的外用药生产企业。
中国医药集团是由国务院国资委直接管理的中国规模较大、产业链较全、综合实力较强的医药健康产业集团。以预防治疗和诊断护理等健康相关产品的分销、零售、研发及生产为主业。
上海现代制药股份有限公司成立于1996年，2004年6月16日在上海证券交易所上市，2010年4月进入中国医药集团总公司，2016年11月，完成国药集团化药工业整合。
国药控股股份有限公司是中国医药集团总公司所属核心企业，成立于2003年1月，2009年9月23日在香港上市（股票代码：01099.HK），系中国较大的药品、医疗保健产品分销商及供应链服务提供商。
公司前身为芜湖三益信成制药有限公司。2012年6月在芜湖市政府的支持下，国药控股与芜湖三益信成制药有限公司和芜湖三益制药有限公司签署股权合作协议，控股芜湖三益信成制药有限公司，吸收合并芜湖三益制药有限公司资产而成。2016年10月20日，根据中国医药集团工业整合战略布署，公司由上海现代制药有限公司与国药控股股份有限公司共同持股。上海现代制药有限公司持股比例为51%，国药控股股份有限公司持股比例为49%。
公司总部位于安徽省芜湖市生物药业科技园（九华北路175号），同时拥有长江路生产基地。总占地面积118亩，公司主要生产皮肤外用药及眼科用药两大类产品，产品行销全国29个省、市、自治区，年销售收入超亿元。
英文翻译：Sanyi Pharmaceutical (Wuhu) Co., Ltd. of Sinopharm group, established in December 2012, is a provincial high-tech enterprise. It is a holding subsidiary of Shanghai Modern Pharmaceutical Co., Ltd. (Stock Code: 600420) and Sinopharm Holding Co., Ltd. (Stock Code: 01099. HK). It is a professional foreign drug manufacturer within China Pharmaceutical Group. China Pharmaceutical Group is a large-scale pharmaceutical and health industry group with complete industrial chain and strong comprehensive strength directly managed by the SASAC of the State Council. The main business is distribution, retail, R & D and production of health-related products such as preventive treatment and diagnostic care. Shanghai Modern Pharmaceutical Co., Ltd. was founded in 1996, listed on Shanghai Stock Exchange on June 16, 2004, and entered China Pharmaceutical Group Corporation in April 2010. In November 2016, it completed the integration of Sinopharm group's chemical pharmaceutical industry. Sinopharm Holding Co., Ltd. is a core enterprise of China Pharmaceutical Group Corporation. It was founded in January 2003 and listed in Hong Kong on September 23, 2009 (Stock Code: 01099. HK). It is a major distributor and supply chain service provider of drugs and healthcare products in China. The predecessor of the company is Wuhu Sanyi Xincheng Pharmaceutical Co., Ltd. In June 2012, with the support of Wuhu Municipal government, Sinopharm signed an equity cooperation agreement with Wuhu Sanyi Xincheng Pharmaceutical Co., Ltd. and Wuhu Sanyi Pharmaceutical Co., Ltd., holding Wuhu Sanyi Xincheng Pharmaceutical Co., Ltd. and absorbing and merging the assets of Wuhu Sanyi Pharmaceutical Co., Ltd. On October 20, 2016, according to the industrial integration strategy of China Pharmaceutical Group, the company was jointly held by Shanghai Modern Pharmaceutical Co., Ltd. and Sinopharm Holding Co., Ltd. The shareholding ratio of Shanghai Modern Pharmaceutical Co., Ltd. is 51%, and that of Sinopharm Holding Co., Ltd. is 49%. The company is headquartered in Wuhu biopharmaceutical science and Technology Park, Anhui Province (No. 175, Jiuhua North Road), and has the production base of Changjiang Road. With a total area of 118 mu, the company mainly produces two kinds of products, skin medicine and ophthalmic medicine. The products are sold in 29 provinces, cities and autonomous regions, with an annual sales revenue of over 100 million yuan.
本文链接： https://www.waitui.com/brand/4ef34ec5f.html 联系电话：0553-5693511,5651605
浙公网安备 33011802001999号
